Related references
Note: Only part of the references are listed.Valproic Acid Stimulates Hippocampal Neurogenesis via Activating the Wnt/β-Catenin Signaling Pathway in the APP/PS1/Nestin-GFP Triple Transgenic Mouse Model of Alzheimer's Disease
Qinghua Zeng et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Amelioration of Behavioral Impairments and Neuropathology by Antiepileptic Drug Topiramate in a Transgenic Alzheimer's Disease Model Mice, APP/PS1
Brice Ayissi Owona et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease
Michael F. Egan et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease
Finn Peters et al.
EMBO JOURNAL (2019)
Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions
David R. Elmaleh et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
BACE1 inhibition more effectively suppresses initiation than progression of beta-amyloid pathology
Finn Peters et al.
ACTA NEUROPATHOLOGICA (2018)
Use of Antiepileptic Drugs and Dementia Riskan Analysis of Finnish Health Register and German Health Insurance Data
Heidi Taipale et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models
C. Y. Daniel Lee et al.
NEURON (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
High plasticity of axonal pathology in Alzheimer's disease mouse models
Lidia Blazquez-Llorca et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis
Ottavio Arancio et al.
ALZHEIMERS & DEMENTIA (2017)
Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease
Katherine R. Sadleir et al.
ACTA NEUROPATHOLOGICA (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Yaming Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
Peng Yuan et al.
NEURON (2016)
Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level
Katherine R. Sadleir et al.
MOLECULAR NEURODEGENERATION (2015)
Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques
Swetha Gowrishankar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-β Deposition in Transgenic Mouse Model of Alzheimer's Disease
Ai-Guo Xuan et al.
MOLECULAR NEUROBIOLOGY (2015)
ALTERED EXPRESSION OF THE VOLTAGE-GATED CALCIUM CHANNEL SUBUNIT α2δ-1: A COMPARISON BETWEEN TWO EXPERIMENTAL MODELS OF EPILEPSY AND A SENSORY NERVE LIGATION MODEL OF NEUROPATHIC PAIN
M. Nieto-Rostro et al.
NEUROSCIENCE (2014)
Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer's Disease
Katherine R. Sadleir et al.
PLOS ONE (2014)
The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
Patty C. Kandalepas et al.
ACTA NEUROPATHOLOGICA (2013)
The α2δ subunits of voltage-gated calcium channels
Annette C. Dolphin
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice
Jian-Quan Shi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Autophagy Enhancer Carbamazepine Alleviates Memory Deficits and Cerebral Amyloid-beta Pathology in a Mouse Model of Alzheimer's Disease
Lixi Li et al.
CURRENT ALZHEIMER RESEARCH (2013)
Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation
William A. Eimer et al.
MOLECULAR NEURODEGENERATION (2013)
Effects of pregabalin on the activity of glutamate transporter type 3
J. H. Ryu et al.
BRITISH JOURNAL OF ANAESTHESIA (2012)
Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease
Nikita Rudinskiy et al.
NATURE NEUROSCIENCE (2012)
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease
Marc Aurel Busche et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition
Carlo Condello et al.
SCIENTIFIC REPORTS (2011)
Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors
Elena Alberdi et al.
CELL CALCIUM (2010)
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
Robert Adalbert et al.
BRAIN (2009)
The role of titration schedule of topiramate for the development of depression in patients with epilepsy
Marco Mula et al.
EPILEPSIA (2009)
The Increased Trafficking of the Calcium Channel Subunit α2δ-1 to Presynaptic Terminals in Neuropathic Pain Is Inhibited by the α2δ Ligand Pregabalin
Claudia S. Bauer et al.
JOURNAL OF NEUROSCIENCE (2009)
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Hong Qing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Amyloid β oligomers (Aβ1-42 globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents
Volker Nimmrich et al.
JOURNAL OF NEUROSCIENCE (2008)
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease
Melanie Meyer-Luehmann et al.
NATURE (2008)
Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks
Kishore V. Kuchibhotla et al.
NEURON (2008)
Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (α2-δ) type 1 protein
C. P. Taylor et al.
NEUROSCIENCE (2008)
Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease
Marc Aurel Busche et al.
SCIENCE (2008)
The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
G. Rosenberg
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
β-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques:: Implications for Alzheimer's disease pathogenesis
Jie Zhao et al.
JOURNAL OF NEUROSCIENCE (2007)
Pharmacology and mechanism of action of pregabalin:: The calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery
Charles P. Taylor et al.
EPILEPSY RESEARCH (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Activity profile of pregabalin in rodent models of epilepsy and ataxia
MG Vartanian et al.
EPILEPSY RESEARCH (2006)
Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: An ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice
F Bian et al.
BRAIN RESEARCH (2006)
Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1
M Ohno et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
Differential distribution of voltage-gated calcium channel alpha-2 delta (α2δ) subunit mRNA-containing cells in the rat central nervous system and the dorsal root ganglia
RL Cole et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Macroautophagy -: a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
WH Yu et al.
JOURNAL OF CELL BIOLOGY (2005)
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers
A Demuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structure-activity relationships of pregabalin and analogues that target the α2-δ protein
TR Belliotti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients
R Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
LB Yang et al.
NATURE MEDICINE (2003)
Food intake, water intake, and drinking spout side preference of 28 mouse strains
AA Bachmanov et al.
BEHAVIOR GENETICS (2002)
β-secretase protein and activity are increased in the neocortex in Alzheimer disease
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2002)
Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2002)
Share Paper
